Shortage Watch Free FDA drug-shortage watch

← all medications

Palovarotene Capsule

Category: Musculoskeletal

Not specified 1

FDA status: To Be Discontinued · Last FDA update: Aug 31, 2026 · First posted: Aug 31, 2026 · 1 manufacturers, 1 listed presentations

As of Aug 31, 2026, the FDA lists Palovarotene Capsule as being discontinued. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Palovarotene Capsule is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
SOHONOS, Capsule, 2.5 mg (NDC 15054-0025-1)
NDC 15054-0025-1
Ipsen Biopharmaceuticals, Inc. Not specified Discontinuation of the manufacture of the drug

Related medications in shortage

Other Musculoskeletal medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Palovarotene Capsule (FDA data as of Aug 31, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Palovarotene Capsule. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Palovarotene Capsule.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/palovarotene-capsule.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).